Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524.

ABSTRACT:

Background

GS-441524 has been successfully used to treat feline infectious peritonitis (FIP) in cats. However, the use of its prodrug, remdesivir, in combination with a PO GS-441524 containing product for the treatment of FIP has not yet been described.

Objectives

Describe treatment protocols, response to treatment and outcomes in cats with FIP treated with a combination of PO GS-441524 and injectable remdesivir.

Animals

Thirty-two client-owned cats diagnosed with effusive or non-effusive FIP including those with ocular and neurological involvement.

Methods

Cats diagnosed with FIP at a single university hospital between August 2021 and July 2022 were included. Variables were recorded from time of diagnosis, and subsequent follow-up information was obtained from

SUBMITTER: Green J 

PROVIDER: S-EPMC10472986 | biostudies-literature | 2023 Sep-Oct

REPOSITORIES: biostudies-literature